INC.

Endotronix erweitert positive Ergebnisse mit der Veröffentlichung von 12-Monats-Daten aus der Studie SIRONA 2 zum Fernmanagement von Herzinsuffizienz mit dem Cordella Pulmonal Artery Sensor Middle East – English USA – English USA – español USA – English Brazil – Português USA – español Latin America – español

by

Die Studie erfüllte die sekundären Studienendpunkte, und die langfristige Verwendung des Sensors war mit signifikanten Verbesserungen der Kennwerte für die Lebensqualität der Patienten sowie niedrigen Ereignisraten bezüglich Hospitalisierung und Todesfällen im Zusammenhang mit Herzinsuffizienz verbunden  LISLE, Illinois, 22. Mai 2023 /PRNewswire/ — Endotronix, Inc., ein Unternehmen für digitale Gesundheits- und Medizintechnik, das sich der Verbesserung der … Read more

Corvia Medical publica los resultados que confirman el beneficio para pacientes con insuficiencia cardiaca

by

– Corvia Medical publica los resultados del ensayo clínico de dos años que confirman el beneficio sostenido y la seguridad de su derivación auricular en pacientes con insuficiencia cardiaca El primer ensayo controlado aleatorizado de fase III de terapia de derivación auricular muestra un beneficio continuo TEWKSBURY, Mass., 22 de mayo de 2023 /PRNewswire/ — … Read more

Aethlon Medical Receives Ethics Board Approval to Add Second Site to its Ongoing Clinical Trial of its Hemopurifier® to Treat Severe COVID-19 in India

by

SAN DIEGO, May 22, 2023 /PRNewswire/ — Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to diagnose and treat cancer and life threatening infectious diseases, today announced that it has received Ethics Review Board (ERB) approval from the Maulana Azad Medical College (MAMC), for a second site for its ongoing … Read more

Pharmaceutical Filtration Market to be Worth $21.96 Billion by 2030: Grand View Research, Inc.

by

SAN FRANCISCO, May 22, 2023 /PRNewswire/ — The global pharmaceutical filtration market size is estimated to reach USD 21.96 billion by 2030, registering a CAGR of 8.03% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 8.03% from 2023 to … Read more

IDEAYA Announces IND Clearance Enabling Phase 1/2 Clinical Trial for Combination of IDE397 and AMG 193 in MTAP-Deletion Solid Tumors

by

IDE397 (MAT2A) and AMG 193 (PRMT5) combination being evaluated in an Amgen-sponsored Phase 1/2 clinical trial in MTAP-deletion solid tumors Potential first-in-class synthetic lethality combination targets mechanistically complementary nodes of the MTAP methylation pathway – MAT2A and PRMT5 Compelling preclinical anti-tumor efficacy presented at AACR 2023 with durable CRs for IDE397 / AMG 193 combination, … Read more

CORVIA MEDICAL RELEASES TWO-YEAR CLINICAL TRIAL RESULTS CONFIRMING SUSTAINED BENEFIT AND SAFETY OF ITS ATRIAL SHUNT IN HEART FAILURE PATIENTS

by

FIRST-EVER PHASE III RANDOMIZED CONTROLLED TRIAL OF ATRIAL SHUNT THERAPY SHOWS CONTINUED PROMISE TEWKSBURY, Mass., May 22, 2023 /PRNewswire/ — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, today announced two-year results from its REDUCE LAP-HF II randomized clinical trial confirming safety and sustained efficacy of the Corvia® Atrial Shunt … Read more

Kelyniam Global Releases Q1 Financials, Announces Licensing Agreement with Bioplate for Osteopore Products

by

CANTON, Conn., May 22, 2023 /PRNewswire/ — Kelyniam Global (OTC: KLYG), a leading maker of custom cranial implants, today announced results for its quarter ended March 31, 2023. “I’m pleased to announce that Kelyniam has expanded our licensing agreement with Bioplate to allow the Company to sell Osteopore products in select markets in the U.S.  Kelyniam will have the opportunity to sell these unique, … Read more

GoHealth Confirms Receipt of Unsolicited Acquisition Proposal From Centerbridge Partners and NVX Holdings

by

CHICAGO, May 19, 2023 /PRNewswire/ — GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace and Medicare-focused digital health company, as noted in a recent 13D filing, has received a proposal from its two largest shareholders to acquire all of the outstanding Class A Common Stock and LLC Interests that these shareholders do not … Read more

Calyxt Announces Stockholder Approval of Merger With Cibus

by

— Calyxt Announces 1-for-5 Reverse Stock Split of Common Stock — ROSEVILLE, Minn., May 19, 2023 /PRNewswire/ — Calyxt, Inc. (Nasdaq: CLXT) (“Calyxt” or the “Company”) today announced the results of the special meeting of its stockholders held on May 18, 2023. At the special meeting, Calyxt’s stockholders voted in favor of all proposals, including … Read more

CMI Health, Inc. Launches AsthmaGo®, Redefining Asthma Management and the Future of Remote Patient Monitoring.

by

Empowering individuals to take control of their asthma.  ATLANTA, May 19, 2023 /PRNewswire/ — CMI Health, Inc., a leading provider of professional medical devices and telemedicine solutions, is proud to announce the launch of AsthmaGo®, an app-based asthma management platform. AsthmaGo® empowers and equips those with asthma and other respiratory conditions, to take control of … Read more